CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Innoviva - INVA CFD

-
0%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 -
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* N/A
开盘价* N/A
1 年变化* N/A
日范围* N/A
52 周范围 10.64-20.71
平均交易量(10 天) 951.64K
平均交易量(3 个月) 14.83M
市值 775.28M
市盈率 4.88
流通股 68.13M
收入 331.34M
EPS 2.33
股息(收益率 %) N/A
贝塔 0.58
下一个财报发布日期 Apr 25, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low

Innoviva Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 331.339 391.866 336.794 261.016 261.004
收入 331.339 391.866 336.794 261.016 261.004
总营业费用 -121.69 16.763 15.671 14.656 22.753
销售/一般/行政费用,总计 63.538 16.187 13.883 14.656 22.753
研究与开发 41.432 0.576 1.788 0 0
营业收入 453.029 375.103 321.123 246.36 238.251
利息收入(费用),非经营净值 -162.707 73.799 33.47 -13.12 -22.294
其他,净值 -3.373 -3.626 -0.348 -0.345 -5.702
税前净收入 286.949 445.276 354.245 232.895 210.255
税后净收入 220.262 368.837 293.814 190.993 406.328
未计算非常项目前的净收益 213.921 265.854 224.402 157.288 395.056
非常规项目总计 0
净收入 213.921 265.854 224.402 157.288 395.056
普通股股东可获收益 (不含非经常性项目) 213.921 265.854 224.402 157.288 395.056
普通股股东可获收益 (含非經常性項目) 213.921 265.854 224.402 157.288 395.056
摊薄净收入 216.36 270.59 229.119 157.288 395.056
摊薄后加权平均股 95.248 94.31 113.554 113.409 113.408
扣除特别项目的每股摊薄盈利 2.27154 2.86915 2.01771 1.38691 3.48349
每股正常摊薄盈利 0.28877 2.86915 2.01771 1.38691 3.48349
少数股东权益 -6.341 -102.983 -69.412 -33.705 -11.272
摊薄调整 2.439 4.736 4.717
收入成本,共计 13.793
毛利 317.546
Depreciation / Amortization 5.581
异常费用(收入) -246.034
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
总收入 65.803 67.257 108.22 90.059 107.68
收入 65.803 67.257 108.22 90.059 107.68
总营业费用 41.622 -221.97 25.666 32.992 3.153
销售/一般/行政费用,总计 17.454 27.81 11.782 6.492 3.113
研究与开发 9.985 11.725 13.884 5.838 0.04
营业收入 24.181 289.227 82.554 57.067 104.527
利息收入(费用),非经营净值 -86.246 -2.831 -61.531 -12.099 -46.448
其他,净值 -2.623 0.028 -0.528 -0.25 -1.59
税前净收入 -64.688 286.424 20.495 44.718 56.489
税后净收入 -68.314 229.347 21.371 37.858 45.65
少数股东权益 0 36.176 -20.432 -22.085 -35.305
未计算非常项目前的净收益 -68.314 265.523 0.939 15.773 10.345
净收入 -68.314 265.523 0.939 15.773 10.345
普通股股东可获收益 (不含非经常性项目) -68.314 265.523 0.939 15.773 10.345
普通股股东可获收益 (含非經常性項目) -68.314 265.523 0.939 15.773 10.345
摊薄调整 3.175 3.654 2.569 1.183
摊薄净收入 -68.314 268.698 4.593 18.342 11.528
摊薄后加权平均股 95.776 95.83 95.653 93.73 81.632
扣除特别项目的每股摊薄盈利 -0.71327 2.8039 0.04802 0.19569 0.14122
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常摊薄盈利 -0.71327 0.57547 0.04802 0.38231 0.14122
异常费用(收入) 0 -266.696 0 20.662
收入成本,共计 10.113 3.68
毛利 55.69 63.577
Depreciation / Amortization 4.07 1.511
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 313.673 342.058 431.234 199.043 200.369
现金和短期投资 201.525 246.487 350.845 114.908 129.075
现金等价物 201.525 246.487 278.096 62.417 73.336
短期投资 0 72.749 52.491 55.739
应收账款总额,净额 110.711 93.931 79.427 83.286 70.54
Accounts Receivable - Trade, Net 110.711 93.931 79.427 83.286 70.54
Prepaid Expenses 1.437 1.64 0.962 0.849 0.754
Total Assets 926.395 999.57 724.826 548.193 367.337
Property/Plant/Equipment, Total - Net 0.012 0.028 0.033 0.16 0.209
Intangibles, Net 111.43 125.253 139.076 152.899 166.722
Other Long Term Assets, Total 17.435 93.973 154.483 196.091 0.037
Total Current Liabilities 5.807 6.11 5.371 5.7 34.742
Accounts Payable 0.027 0.066 0.01 0.011 0.601
Accrued Expenses 5.78 6.044 5.361 5.689 9.141
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 25
Other Current Liabilities, Total 0
Total Liabilities 511.652 459.658 411.331 394.61 610.196
Total Long Term Debt 394.653 385.517 377.12 382.855 574.362
Long Term Debt 394.653 385.517 377.12 382.855 574.362
Other Liabilities, Total 0 0.106 0.219 0.586 0.94
Total Equity 414.743 539.912 313.495 153.583 -242.859
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.696 1.014 1.013 1.011 1.019
Additional Paid-In Capital 1264.02 1260.9 1258.86 1256.27 1258.15
Retained Earnings (Accumulated Deficit) -456.148 -722.002 -946.404 -1103.69 -1498.75
Treasury Stock - Common -393.829 0 -3.263
Other Equity, Total 0 0.027 -0.003 -0.018
Total Liabilities & Shareholders’ Equity 926.395 999.57 724.826 548.193 367.337
Total Common Shares Outstanding 69.5655 101.392 101.288 101.098 101.896
Minority Interest 111.192 67.925 28.621 5.469 0.152
Long Term Investments 483.845 438.258
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 317.823 313.673 236.928 148.261 372.933
现金和短期投资 216.802 201.525 135.115 43.265 282.89
现金等价物 216.802 201.525 135.115 43.265 282.89
应收账款总额,净额 93.515 110.711 101.271 104.262 88.974
Accounts Receivable - Trade, Net 93.515 110.711 101.271 104.262 88.974
Prepaid Expenses 5.576 1.437 0.542 0.734 1.069
Total Assets 1107.47 926.395 887.239 789.15 1088.29
Property/Plant/Equipment, Total - Net 3.985 0.012 0.015 0.019 0.024
Intangibles, Net 212.974 111.43 114.885 118.341 121.797
Long Term Investments 544.437 483.845 507.116 473.677 519.325
Other Long Term Assets, Total 22.711 17.435 28.295 48.852 74.211
Total Current Liabilities 109.227 5.807 3.125 5.371 3.804
Accounts Payable 1.808 0.027 0.089 0.03 0.014
Accrued Expenses 11.403 5.78 3.036 5.341 3.79
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 720.832 511.652 484.428 459.37 453.829
Total Long Term Debt 442.731 394.653 392.295 389.989 387.728
Long Term Debt 442.731 394.653 392.295 389.989 387.728
Minority Interest 165.575 111.192 88.994 63.965 62.22
Other Liabilities, Total 3.299 0 0.014 0.045 0.077
Total Equity 386.642 414.743 402.811 329.78 634.461
Common Stock 0.696 0.696 0.695 0.695 1.014
Additional Paid-In Capital 1182.91 1264.02 1262.44 1261.84 1261.33
Retained Earnings (Accumulated Deficit) -403.137 -456.148 -466.493 -538.931 -627.879
Total Liabilities & Shareholders’ Equity 1107.47 926.395 887.239 789.15 1088.29
Total Common Shares Outstanding 69.594 69.5655 69.492 69.495 101.408
Preferred Stock - Non Redeemable, Net 0 0 0 0
Treasury Stock - Common -393.829 -393.829 -393.829 -393.829
Other Current Assets, Total 1.93
Goodwill, Net 5.544
Current Port. of LT Debt/Capital Leases 96.016
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 368.837 293.814 190.993 406.328 134.272
经营活动产生的现金 363.813 313.113 257.458 223.531 141.749
经营活动产生的现金 13.832 13.84 13.874 13.872 13.982
非现金物品 -78.415 -40.639 7.621 16.145 21.775
已付现金利息 9.933 9.933 10.974 17.861 40.353
营运资金的变化 -16.873 -14.322 3.095 -16.76 -28.28
投资活动产生的现金 43.722 -314.937 -18.003 3.519 -23.236
资本支出 0 -0.013 -0.012 0 0
其他投资现金流量项目,总计 43.722 -314.924 -17.991 3.519 -23.236
融资活动产生的现金 -452.497 -29.785 -23.776 -237.969 -163.193
融资现金流项目 -59.457 -30.129 -10.553 -5.955 0.023
Total Cash Dividends Paid 0 0 -0.011 -0.08 -0.281
股票的发行(报废),净额 -393.04 0.344 0.538 -1.934 -99.193
债务的发行(退还),净额 0 0 -13.75 -230 -63.742
现金净变化 -44.962 -31.609 215.679 -10.919 -44.68
Deferred Taxes 76.432 60.42 41.875 -196.054
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 37.858 368.837 323.187 220.541 109.695
Cash From Operating Activities 98.102 363.813 265.432 168.721 84.107
Cash From Operating Activities 3.501 13.832 10.376 6.918 3.46
Deferred Taxes 6.86 76.432 65.6 45.069 19.736
Non-Cash Items 31.684 -78.415 -124.495 -93.637 -52.003
Cash Interest Paid 5.411 9.933 9.933 4.967 4.967
Changes in Working Capital 18.199 -16.873 -9.236 -10.17 3.219
Cash From Investing Activities -143.156 43.722 63.627 63.627 -26.394
Capital Expenditures -0.009 0 0 0 0
Other Investing Cash Flow Items, Total -143.147 43.722 63.627 63.627 -26.394
Cash From Financing Activities 60.331 -452.497 -440.431 -435.57 -21.31
Financing Cash Flow Items -6.507 -59.457 -46.358 -41.446 -21.285
Issuance (Retirement) of Stock, Net 0.214 -393.04 -394.073 -394.124 -0.025
Net Change in Cash 15.277 -44.962 -111.372 -203.222 36.403
Total Cash Dividends Paid 0
Issuance (Retirement) of Debt, Net 66.624 0
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
BlackRock Institutional Trust Company, N.A. Investment Advisor 14.3359 9766472 318524 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 10.3365 7041846 54802 2022-12-31 LOW
Sarissa Capital Management, L.P. Hedge Fund 9.7085 6614000 0 2022-12-31 LOW
Putnam Investment Management, L.L.C. Investment Advisor/Hedge Fund 7.3406 5000852 49183 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 6.2085 4229607 -36066 2022-12-31 HIGH
Westfield Capital Management Company, L.P. Investment Advisor/Hedge Fund 6.0273 4106136 145968 2022-12-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 4.7077 3207194 271075 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.3086 2253988 -216906 2022-12-31 LOW
Millennium Management LLC Hedge Fund 3.1327 2134156 -369816 2022-12-31 HIGH
Systematic Financial Management, L.P. Investment Advisor 2.8675 1953525 114784 2022-12-31 LOW
Assenagon Asset Management S.A. Investment Advisor 2.5143 1712874 -190058 2022-12-31 HIGH
LSV Asset Management Investment Advisor 2.4093 1641361 -1120342 2022-12-31 LOW
Pacer Advisors, Inc. Investment Advisor 2.2585 1538654 63256 2022-12-31 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.7568 1196821 46886 2022-12-31 LOW
Citadel Advisors LLC Hedge Fund 1.4466 985539 147595 2022-12-31 HIGH
D. E. Shaw & Co., L.P. Hedge Fund 1.4372 979124 46803 2022-12-31 MED
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 1.045 711936 164118 2022-12-31 LOW
BofA Global Research (US) Research Firm 0.9805 667991 -8277 2022-12-31 LOW
Goldman Sachs & Company, Inc. Research Firm 0.9348 636816 -350775 2022-12-31 MED
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.9296 633331 25245 2022-12-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Innoviva Company profile

关于 Innoviva

Innoviva, Inc.是一家拥有特许权使用费和其他医疗保健资产组合的公司。 其特许权使用费组合包括与葛兰素集团有限公司(GSK)合作的呼吸系统资产,包括RELVAR/BREO ELLIPTA(糠酸氟替卡松/维兰特罗,FF/VI)、ANORO ELLIPTA(UMEClidinium bromide/维兰特罗,UMEC/VI)和TRELEGY ELLIPTA(FF/UMEC/VI组合)。 根据长效β2受体激动剂(LABA)合作协议,Innoviva有权从葛兰素史克公司获得RELVAR/BREO ELLIPTA的销售版税以及ANORO和ELLIPTA的销售版税。 RELVAR/BREO是一种每日一次的组合药物,由LABA、维兰特罗(VI)和吸入性皮质类固醇(ICS)以及糠酸氟替卡松(FF)组成。 ANORO ELLIPTA是由长效毒蕈碱拮抗剂(LAMA)、UMEC溴化铵(UMEC)和LABA(VI)组成的每日一次的药物。 TRELEGY ELLIPTA是一种由ICS、LAMA和LABA组成的每日一次的复合药。

Industry: Pharmaceuticals (NEC)

1350 Old Bayshore Highway
Suite 400
94010

收入报表

  • Annual
  • Quarterly

人们也观看

US100

12,837.30 Price
+1.640% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 3.0

BTC/USD

28,431.35 Price
+3.860% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 66.00

Gold

1,964.70 Price
-0.460% 1D Chg, %
多头隔夜费 -0.0087%
空头隔夜费 0.0005%
隔夜费时间 21:00 (UTC)
价差 0.30

Oil - Crude

72.85 Price
-1.030% 1D Chg, %
多头隔夜费 -0.0162%
空头隔夜费 -0.0057%
隔夜费时间 21:00 (UTC)
价差 0.03

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易